JPRN-UMIN000015033已完成4 期
Comparison of DPP-4 Inhibitors versus Dapagliflozin in combination with insulin using continuous glucose monitoring in patients with type 2 diabetes mellitus -prospective randomized controlled trial- - Comparison of DPP-4 Inhibitors vs. Dapagliflozin in combination with insulin using CGM
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 36
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) severe hepatic dysfunction, renal dysfunction, heart failure, 2) history of anaphylaxis of drugs we use, 3) pregnancy, 4) lower than 45ml/min of eGFR, 5)lower Body mass index than 22kg/m2 6) patients who are inadequate to enter this study due to the other reasons by physician's judgments
研究者
相似试验
已完成
不适用
Comparison of DPP4 inhibitors versus luseogliflozin, a SGLT2 inhibitor using cotinuous glucose monitoring (CGM)type 2 diabetesJPRN-UMIN000014333Ichinomiyanishi hospital20
已完成
不适用
Comparison of efficacy between DPP-4 inhibitor up-titration vs addition of acarbose in T2DMtype 2 diabetes mellitusJPRN-UMIN000005471Saitama Medical University40
招募中
不适用
Comparison of effects of a DPP-4 inhibitor and an alpha-glucosidase inhibitor on visceral fat and oxidative stress in type 2 diabetes mellitustype 2 diabetes mellitusJPRN-UMIN000011864Tokyo Women's Medical University100
已完成
不适用
Comparison of DPP-4 inhibitors, vildagliptin and linagliptin in type2 diabetesType 2 diabetes mellitusJPRN-UMIN000010445Yokohama City University Medical Center100
已完成
不适用
Examination of the usefulness of DPP-4 inhibitor in the treatment of type 2 diabetesType 2 diabetesJPRN-UMIN000011862aka Kinen Clinic10